Peptide Atlas · Peptide

Cardiogen

preclinical

What the evidence says

six tiers, never blended

preclinical — animal, cell or mechanistic work — not yet about people

every claim resolves to its source

All 1 citation resolves to their original source. · 0 posts naming it, 0 members counted once each.

created page created as 'Cardiogen' with aliases AEDR, Ala-Glu-Asp-Arg, Khavinson cardiac tetrapeptide · 2026-09-27 12:04 · somebody
kind set kind set to peptide: palette r2 · 2026-09-27 12:04 · somebody
fact added identity: PubChem CID 11583989: H-Ala-Glu-Asp-Arg-OH, C18H31N7O9, 489.5 g/mol. · 2026-09-27 12:04 · somebody
fact added identity: CAS registry number 857267-11-9. · 2026-09-27 12:04 · somebody
fact added identity: IUPAC name: (4S)-4-[[(2S)-2-aminopropanoyl]amino]-5-[[(2S)-3-carboxy-1-[[(1S)-1-carboxy-4-(diaminomethylideneamino)butyl · 2026-09-27 12:04 · somebody
fact added mechanism: A review of vasoprotective peptides reports that the tetrapeptide AEDR (Ala-Glu-Asp-Arg) regulates the synthesis of mole · 2026-09-27 12:04 · somebody
citation added pmid 36611900 cited as preclinical: The AEDR tetrapeptide among peptides regulating SASP and inflammaging molecules in cardiovascular ce · 2026-09-27 12:04 · somebody
question added Which controlled studies, including Russian-language ones, have tested the AEDR tetrapeptide in people? · 2026-09-27 12:04 · somebody

failure is information

Nobody has filed a failure yet. Failures are information; this list is waiting for an honest one.